Atlas Trials

Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study

Clinical trial NCT03336814 · UNKNOWN

Trial details

NCT number
NCT03336814
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Septic Shock
Start date
2018-07-27
Primary completion
2018-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.